rs16850096
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_006922.4(SCN3A):c.4476T>C(p.Tyr1492Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00188 in 1,613,756 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0038 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 34 hom. )
Consequence
SCN3A
NM_006922.4 synonymous
NM_006922.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.197
Publications
2 publications found
Genes affected
SCN3A (HGNC:10590): (sodium voltage-gated channel alpha subunit 3) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family, and is found in a cluster of five alpha subunit genes on chromosome 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SCN3A Gene-Disease associations (from GenCC):
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
- developmental and epileptic encephalopathy, 62Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- epilepsy, familial focal, with variable foci 4Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 2-165094434-A-G is Benign according to our data. Variant chr2-165094434-A-G is described in ClinVar as Benign. ClinVar VariationId is 412603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.197 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00375 (571/152238) while in subpopulation EAS AF = 0.0198 (102/5162). AF 95% confidence interval is 0.0167. There are 6 homozygotes in GnomAd4. There are 277 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 571 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN3A | NM_006922.4 | c.4476T>C | p.Tyr1492Tyr | synonymous_variant | Exon 26 of 28 | ENST00000283254.12 | NP_008853.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN3A | ENST00000283254.12 | c.4476T>C | p.Tyr1492Tyr | synonymous_variant | Exon 26 of 28 | 1 | NM_006922.4 | ENSP00000283254.7 |
Frequencies
GnomAD3 genomes AF: 0.00375 AC: 570AN: 152120Hom.: 6 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
570
AN:
152120
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00387 AC: 972AN: 251328 AF XY: 0.00398 show subpopulations
GnomAD2 exomes
AF:
AC:
972
AN:
251328
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00168 AC: 2458AN: 1461518Hom.: 34 Cov.: 30 AF XY: 0.00193 AC XY: 1403AN XY: 727074 show subpopulations
GnomAD4 exome
AF:
AC:
2458
AN:
1461518
Hom.:
Cov.:
30
AF XY:
AC XY:
1403
AN XY:
727074
show subpopulations
African (AFR)
AF:
AC:
268
AN:
33454
American (AMR)
AF:
AC:
44
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26120
East Asian (EAS)
AF:
AC:
651
AN:
39670
South Asian (SAS)
AF:
AC:
1128
AN:
86244
European-Finnish (FIN)
AF:
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
116
AN:
1111758
Other (OTH)
AF:
AC:
245
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
132
263
395
526
658
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00375 AC: 571AN: 152238Hom.: 6 Cov.: 32 AF XY: 0.00372 AC XY: 277AN XY: 74426 show subpopulations
GnomAD4 genome
AF:
AC:
571
AN:
152238
Hom.:
Cov.:
32
AF XY:
AC XY:
277
AN XY:
74426
show subpopulations
African (AFR)
AF:
AC:
356
AN:
41554
American (AMR)
AF:
AC:
27
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
102
AN:
5162
South Asian (SAS)
AF:
AC:
73
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7
AN:
68014
Other (OTH)
AF:
AC:
6
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
69
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 13, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.